scholarly article | Q13442814 |
editorial | Q871232 |
P50 | author | Lawrence S Young | Q56861870 |
P2093 | author name string | Lawrence S Young | |
P2860 | cites work | Epstein-Barr virus and the origin of Hodgkin lymphoma | Q26998999 |
MicroRNAs in nasopharyngeal carcinoma | Q34572800 | ||
Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells | Q35020438 | ||
Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells | Q38249886 | ||
Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma | Q38249887 | ||
Epstein-Barr virus infection mechanisms | Q38260827 | ||
The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma | Q38264787 | ||
Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma | Q38270678 | ||
Epstein-Barr virus and Burkitt lymphoma. | Q38270680 | ||
Epstein-Barr virus and nasopharyngeal carcinoma | Q56947843 | ||
P433 | issue | 11 | |
P921 | main subject | Epstein–Barr virus | Q6900 |
P304 | page(s) | 527-528 | |
P577 | publication date | 2014-11-01 | |
P1433 | published in | Chinese Journal of Cancer | Q15760211 |
P1476 | title | Epstein-Barr virus at 50-future perspectives | |
P478 | volume | 33 |
Q100945769 | Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
Q28077209 | Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis |
Q36121349 | Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis |
Q92538156 | Epstein-Barr Virus Nuclear Antigen 1 Recruits Cyclophilin A to Facilitate the Replication of Viral DNA Genome |
Q90835372 | Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells |
Q36055637 | Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells |
Q54112589 | The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling. |
Q36562258 | The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB. |
Q92739710 | Using regulatory variants to detect gene-gene interactions identifies networks of genes linked to cell immortalisation |
Q59332852 | Vasculogenic mimicry formation in EBV-associated epithelial malignancies |
Search more.